Exchange: OTC·Updated 10:57 AM EDT

QBIO Q BioMed Inc

$0.00
$0.00
(0.00%)
Today
Mkt Cap$145.00
Vol100.00

About QBIO

Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
50

Neutral Sentiment

How do you feel about QBIO?

Advertisement|Remove ads.